Logos Global Management LP Global Blood Therapeutics, Inc. Transaction History

Logos Global Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $27.9 Million - $46.7 Million	-1,250,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $12.8 Million - $17.8 Million	500,000 Added 66.67%	1,250,000 $43.3 Million
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $18.7 Million - $30.2 Million	750,000 New	750,000 $22 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $32 Million - $54.2 Million	-850,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $37.7 Million - $53.3 Million	715,000 Added 529.63%	850,000 $46.9 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $2.48 Million - $4.17 Million	-50,933 Reduced 27.39%	135,000 $8.52 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $7.76 Million - $16.2 Million	185,933 New	185,933 $9.5 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.